Your search returned 4 results.

Results
	1.	Inhalation devices for long-acting beta2-agonists: efficiency and ease of use of dry powder formoterol inhalers for use by patients with asthma and COPD. [electronic resource] by Molimard, Mathieu Till, Denise Stenglein, Stephan Singh, Dilraj Krummen, Markus Producer: 20101108 In: Current medical research and opinion vol. 23 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Formoterol mono- and combination therapy with tiotropium in patients with COPD: a 6-month study. [electronic resource] by Vogelmeier, Claus Kardos, Peter Harari, Sergio Gans, Steven J M Stenglein, Stephan Thirlwell, Jackie Producer: 20090105 In: Respiratory medicine vol. 102 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Onset and duration of action of formoterol and tiotropium in patients with moderate to severe COPD. [electronic resource] by Richter, Kai Stenglein, Stephan Mücke, Marion Sieder, Christian Schmidtmann, Sören Harnest, Ulf Weidinger, Gottfried Magnussen, Helgo Producer: 20061114 In: Respiration; international review of thoracic diseases vol. 73 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Treatment with omalizumab normalizes the number of myeloid dendritic cells during the grass pollen season. [electronic resource] by Feuchtinger, Tobias Bartz, Holger von Berg, Andrea Riedinger, Frank Brauburger, Jens Stenglein, Stephan Wahn, Ulrich Schauer, Uwe Producer: 20030325 In: The Journal of allergy and clinical immunology vol. 111 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)